Enhancer variants: evaluating functions in common disease

Gene enhancer elements are noncoding segments of DNA that play a central role in regulating transcriptional programs that control development, cell identity, and evolutionary processes. Recent studies have shown that noncoding single nucleotide polymorphisms (SNPs) that have been associated with risk for numerous common diseases through genome-wide association studies frequently lie in cell-type-specific enhancer elements. These enhancer variants probably influence transcriptional output, thereby offering a mechanistic basis to explain their association with risk for many common diseases. This review focuses on the identification and interpretation of disease-susceptibility variants that influence enhancer function. We discuss strategies for prioritizing the study of functional enhancer SNPs over those likely to be benign, review experimental and computational approaches to identifying the gene targets of enhancer variants, and highlight efforts to quantify the impact of enhancer variants on target transcript levels and cellular phenotypes. These studies are beginning to provide insights into the mechanistic basis of many common diseases, as well as into how we might translate this knowledge for improved disease diagnosis, prevention and treatments. Finally, we highlight five major challenges often associated with interpreting enhancer variants, and discuss recent technical advances that may help to surmount these challenges.

[1]  Bernhard Horsthemke,et al.  Leveraging Cross-Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms , 2014, Cell.

[2]  Nathan C. Sheffield,et al.  The accessible chromatin landscape of the human genome , 2012, Nature.

[3]  Swneke D. Bailey,et al.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.

[4]  T. Meehan,et al.  An atlas of active enhancers across human cell types and tissues , 2014, Nature.

[5]  Naomi R. Wray,et al.  Regulatory variants explain much more heritability than coding variants across 11 common diseases , 2014, bioRxiv.

[6]  M. Nóbrega,et al.  An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. , 2010, Genome research.

[7]  Wendy A Bickmore,et al.  The spatial organization of the human genome. , 2013, Annual review of genomics and human genetics.

[8]  Emmanouil T. Dermitzakis,et al.  Putative cis-regulatory drivers in colorectal cancer , 2014, Nature.

[9]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[10]  Michael D. Cole,et al.  Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells , 2010, Molecular and Cellular Biology.

[11]  Daniel C. Factor,et al.  Epigenomic comparison reveals activation of "seed" enhancers during transition from naive to primed pluripotency. , 2014, Cell stem cell.

[12]  W. Bickmore,et al.  H4K16 acetylation marks active genes and enhancers of embryonic stem cells, but does not alter chromatin compaction , 2013, Genome research.

[13]  J. Dekker,et al.  Capturing Chromosome Conformation , 2002, Science.

[14]  Daniel Panne,et al.  The enhanceosome. , 2008, Current opinion in structural biology.

[15]  Christopher A. Haiman,et al.  The 8q24 cancer risk variant rs6983267 demonstrates long-range interaction with MYC in colorectal cancer , 2009, Nature Genetics.

[16]  N. Cox,et al.  Obesity-associated variants within FTO form long-range functional connections with IRX3 , 2014, Nature.

[17]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[18]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[19]  Alex P. Reynolds,et al.  Exonic Transcription Factor Binding Directs Codon Choice and Affects Protein Evolution , 2013, Science.

[20]  P. Gaffney,et al.  An Enhancer Element Harboring Variants Associated with Systemic Lupus Erythematosus Engages the TNFAIP3 Promoter to Influence A20 Expression , 2013, PLoS genetics.

[21]  R. Andrews,et al.  Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression , 2014, Science.

[22]  Stephen C. J. Parker,et al.  Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants , 2013, Proceedings of the National Academy of Sciences.

[23]  R. Krumlauf,et al.  A regulatory module embedded in the coding region of Hoxa2 controls expression in rhombomere 2 , 2008, Proceedings of the National Academy of Sciences.

[24]  R. D. Hawkins,et al.  Methods for identifying higher-order chromatin structure. , 2012, Annual review of genomics and human genetics.

[25]  Boris Lenhard,et al.  Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions , 2013, Genome research.

[26]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[27]  G. Semenza,et al.  The silent carrier allele: β thalassemia without a mutation in the β-globin gene or its immediate flanking regions , 1984, Cell.

[28]  J. Dekker,et al.  The long-range interaction landscape of gene promoters , 2012, Nature.

[29]  María M. Abad-Grau,et al.  Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis , 2012, Journal of Medical Genetics.

[30]  Buhm Han,et al.  Chromatin marks identify critical cell types for fine mapping complex trait variants , 2012 .

[31]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[32]  W. D. Laat,et al.  A Decade of 3c Technologies: Insights into Nuclear Organization References , 2022 .

[33]  G. Bejerano,et al.  Coding exons function as tissue-specific enhancers of nearby genes , 2012, Genome research.

[34]  W. Sung,et al.  Chromatin connectivity maps reveal dynamic promoter–enhancer long-range associations , 2013, Nature.

[35]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[36]  Sampsa Hautaniemi,et al.  Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. , 2012, Cancer genetics.

[37]  Stephen C. J. Parker,et al.  Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. , 2010, Cell metabolism.

[38]  Joseph B Hiatt,et al.  Massively parallel functional dissection of mammalian enhancers in vivo , 2012, Nature Biotechnology.

[39]  Simon G. Coetzee,et al.  Comprehensive Functional Annotation of Seventy-One Breast Cancer Risk Loci , 2013, PloS one.

[40]  Karen L. Mohlke,et al.  A map of open chromatin in human pancreatic islets , 2010, Nature Genetics.

[41]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[42]  K. Tan,et al.  Global view of enhancer–promoter interactome in human cells , 2014, Proceedings of the National Academy of Sciences.

[43]  Benjamin P. Berman,et al.  FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs , 2012, Nucleic acids research.

[44]  Ryan A. Flynn,et al.  A unique chromatin signature uncovers early developmental enhancers in humans , 2011, Nature.

[45]  B. Steensel,et al.  Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture–on-chip (4C) , 2006, Nature Genetics.

[46]  Karen Cheng,et al.  Disease-Related Growth Factor and Embryonic Signaling Pathways Modulate an Enhancer of TCF21 Expression at the 6q23.2 Coronary Heart Disease Locus , 2013, PLoS genetics.

[47]  A. Stark,et al.  Transcriptional enhancers: from properties to genome-wide predictions , 2014, Nature Reviews Genetics.

[48]  W. Schaffner,et al.  Transcriptional enhancers can act in trans. , 1990, Trends in genetics : TIG.

[49]  A. Wilkie,et al.  A variant in the sonic hedgehog regulatory sequence (ZRS) is associated with triphalangeal thumb and deregulates expression in the developing limb , 2008, Human molecular genetics.

[50]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[51]  Lee E. Edsall,et al.  A map of the cis-regulatory sequences in the mouse genome , 2012, Nature.

[52]  Anna Murray,et al.  Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis , 2013, Nature Genetics.

[53]  Gabor T. Marth,et al.  Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics , 2013, Science.

[54]  Matthew C. Canver,et al.  An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level , 2013, Science.

[55]  B. Oostra,et al.  A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. , 2003, Human molecular genetics.

[56]  Yan Li,et al.  A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.

[57]  D. Kioussis,et al.  β-Globin gene inactivation by DNA translocation in γβ-thalassaemi , 1983, Nature.

[58]  Aravinda Chakravarti,et al.  Evaluation of the RET regulatory landscape reveals the biological relevance of a HSCR-implicated enhancer. , 2005, Human molecular genetics.

[59]  Nancy F. Hansen,et al.  An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. , 2014, American journal of human genetics.

[60]  Swneke D. Bailey,et al.  Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus , 2012, Genome research.

[61]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[62]  Leighton J. Core,et al.  Coordinated Effects of Sequence Variation on DNA Binding, Chromatin Structure, and Transcription , 2013, Science.

[63]  G. Kreiman,et al.  Widespread transcription at neuronal activity-regulated enhancers , 2010, Nature.

[64]  P. Scacheri,et al.  Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. , 2011, Genome research.

[65]  Jason H. Moore,et al.  Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer , 2012, Science.

[66]  F. Vannberg,et al.  GENETICS OF GENE EXPRESSION IN PRIMARY IMMUNE CELLS IDENTIFIES CELL-SPECIFIC MASTER REGULATORS AND ROLES OF HLA ALLELES , 2012, Nature Genetics.

[67]  T. Mikkelsen,et al.  Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. , 2013, Genome research.

[68]  Raymond K. Auerbach,et al.  Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation , 2012, Cell.

[69]  E. Grice,et al.  A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk , 2005, Nature.

[70]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[71]  W. Schaffner,et al.  An enhancer stimulates transcription in Trans when attached to the promoter via a protein bridge , 1989, Cell.

[72]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[73]  Wendy A. Bickmore,et al.  Anterior-posterior differences in HoxD chromatin topology in limb development , 2012, Development.

[74]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[75]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[76]  C. Gieger,et al.  Restless Legs Syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon , 2014, Genome research.

[77]  Mark I. McCarthy,et al.  Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants , 2013, Nature Genetics.

[78]  S. Kato,et al.  A Trans‐Acting Enhancer Modulates Estrogen‐Mediated Transcription of Reporter Genes in Osteoblasts , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  Simon G. Coetzee,et al.  Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci , 2014, PLoS genetics.

[80]  Liqun Luo,et al.  A molecular basis for classic blond hair color in Europeans , 2014, Nature Genetics.

[81]  M. Lupien,et al.  Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits , 2014, Genome research.